They found that the anti-tumor immune response showed a decline from MGUS, SMM to MM, evident by a general decrease in naïve and memory CD4+ T cells and an increase of Treg together with CD8+ Eff 2 cells with an inhibitory phenotype. This evidence concerns the gene CD8A and Miyoshi myopathy.